Valerio   Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3
Founded: Paris France (1997)
Status: Left NME R&D (2023)

Organization Overview

First Clinical Trial
2001
NCT00548561
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

BioAlliance Pharma | Onxeo